Marker Therapeutics (MRKR) Q4 2025 Earnings

Nov 14Confirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.53
-0.39
-0.26
-0.12

Details

Expected EPS
-0.36
Actual EPS
-0.12
Surprise EPS
0.24
Surprise Percent
+66.67%

Description

⁨Marker Therapeutics⁩ (⁦MRKR⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts